Careteq Ltd.

As of June 30, 2024, Careteq Ltd. carries a market capitalization of 3.08M, placing it among publicly traded companies globally. Its enterprise value stands at 3.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Careteq Ltd.'s next confirmed earnings release is scheduled for March 1, 2027.

As of June 30, 2024, Careteq Ltd. has 237.12M shares outstanding.

These figures are as of June 30, 2024. The price-to-sales ratio is 0.39, and the price-to-book ratio stands at 1.56.

These figures are as of June 30, 2024. The EV/Sales ratio of 0.49 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 3.58M versus a market cap of 3.08M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2024, Careteq Ltd. maintains a current ratio of 1.31, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.48, indicating elevated leverage, while an interest coverage ratio of -13.30 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2024, Careteq Ltd. posted a negative return on equity (ROE) of -132.18, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -37.39, reflecting losses generated across the asset base.

Over the twelve months ended June 30, 2024, Careteq Ltd. recorded 330,381.00 in income tax expense. The company reported a pretax loss of -1.40M and -2.72M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Careteq Ltd.'s stock has gained approximately 18.18% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.

Over the twelve months ended June 30, 2024, Careteq Ltd. generated 7.23M in revenue and converted that into -2.72M in net income, yielding earnings per share of -0.01. EBITDA reached -1.44M, while operating income came in at -1.93M.

As of June 30, 2024, Careteq Ltd. holds 1.25M in cash and equivalents against 192,978.00 in total debt, resulting in a net debt position of -1.25M. Total book value stands at 1.97M, with working capital of 943,890.00 providing operational flexibility.

These figures cover the twelve months ended June 30, 2024.

These figures cover the twelve months ended June 30, 2024. The operating margin of -26.68 and net profit margin of -37.58 provide insight into operational efficiency.

Over the twelve months ended June 30, 2024, Careteq Ltd. paid dividends of 0.00 per share. The dividend payout ratio of -7.18 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -52.91, meaning Careteq Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Careteq Ltd.'s most recent stock split took place on August 2, 2023 with a 55:63 split ratio.

As of June 30, 2024, Careteq Ltd. has an Altman Z-Score of -6.76, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.